• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Tikosyn (dofetilide) Capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

 

December 2013

Summary View

CONTRAINDICATIONS

  • …In addition, other known inhibitors of the renal cation transport system such as… dolutegravir should not be used in patients on TIKOSYN
     

 

July 2011

Summary View

Medication Guide (new)